Introduction
Multidrug resistance (MDR) to antimicrobial agents is a growing concern with Salmonella as it limits treatment options for invasive disease and could lead to the transfer of resistance to other pathogenic organisms. The first Salmonella 4, [5] ,12:i:-was identified in the late 1980s from poultry in Portugal and between 1998 and 2004 it was the fourth most common serovar in Spain. 1, 2 Phage type U302 with a resistance profile of ACSuGSTTm (see Table 1 for abbreviations) was the predominant resistance type. Since that time, Salmonella 4, [5] ,12:i:-has become a predominant serotype in many countries including Italy, the UK and France; and outbreaks have been reported in Luxembourg, Austria, Ireland, Germany and the Netherlands. resistance patterns in the Salmonella 4, [5] ,12:i:-in these countries as a majority of isolates had a multidrug-resistant phenotype of ASSuT with a phage type of DT193/DT120 predominating. 4 As of 2007, Salmonella 4, [5] ,12:i:-has become the fifth most common serovar in Canada. 5 This report describes the emergence and characteristics of MDR present in this serovar in Canada.
Methods

Study design
The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) was established in 2003 (see http://www.phac-aspc.gc. ca/cipars-picra/surv-eng.php for details). Salmonella isolates identified from Alberta, British Columbia, Ontario and Québec were submitted from days 1 -15 of each month, whereas all other provinces submitted all Salmonella isolates.
Phenotypic characterization
Serotyping was conducted using the standard methodologies used at each provincial laboratory. Phage typing was conducted as previously described. 6 Antimicrobial susceptibilities to 15 antibiotics were determined using the broth microdilution method (Sensititre Automated Microbiology System; Trek Diagnostic Systems Ltd, Westlake, OH, USA) using established CLSI breakpoints 7 or interpretive criteria harmonized with the National Antimicrobial Resistance Monitoring System when no formal breakpoints were available.
Genotypic characterization
All isolates that displayed a core antimicrobial resistance phenotype to ampicillin, streptomycin, sulphonamides and tetracycline (ASSuT) were characterized. PCR was performed on all isolates with a core resistance phenotype of ASSuT and ACSSuT as previously described. 8, 9 Multiplex PCR to detect extended-spectrum b-lactamase genes (for TEM, SHV, CTX and CMY-2) was conducted on all isolates with a ceftiofur MIC of ≥8 mg/L. 10 Multilocus sequence typing (MLST) was performed on a subset of isolates based on unique phage types and antimicrobial susceptibility patterns according to the method described by Harbottle et al. 11 Data were submitted to the MLST database web site to determine sequence types (STs; http://mlst.ucc.ie/mlst/dbs/Senterica).
Statistical analysis
Multivariate analysis using PROC LOGISTIC (SAS version 9.3; SAS Institute Inc., USA) was conducted to compare the presence of Salmonella 4, [5] ,12:i:-and antimicrobial resistance across years and provinces. 12 None of the bloodstream infections reported in this study was considered to be multidrug resistant (resistance to three or more classes of antibiotics). The regional distribution over the time period was as follows: western provinces (British Columbia, Alberta, Saskatchewan and Manitoba; 55.2%, n¼423), central provinces (Ontario and Quebec; 38.4%, n¼294) and eastern provinces (Nova Scotia, New Brunswick, Newfoundland and Prince Edward Island; 6.4%, n¼49). A dramatic increase occurred in the number of cases since 2006 in western Canada compared with the other regions of Canada (Figure 1 ).
Results and discussion
Of the 766 Salmonella 4, [5] ,12:i:-submitted for antimicrobial susceptibility testing, the majority of isolates (n¼ 456; 59.5%) remained susceptible to all antimicrobials tested. Quinolone resistance was rare, with only 13 isolates resistant to nalidixic acid and one isolate resistant to ciprofloxacin. Of concern was that the single ciprofloxacin-resistant isolate was also resistant to all the other antimicrobial resistance classes tested (Table 1 ). In addition, there were 119 (15.5%) isolates that had a multidrug-resistant phenotype, and the majority of the multidrug-resistant isolates (n¼ 91; 76.5%) had a core R-type of ASSuT. The geographical distribution of these isolates was as follows: western provinces (n¼26), central provinces (n¼ 58) and eastern provinces ( The majority of isolates with an R-type of ASSuT+ had the ASSuT phenotype (n ¼63; 68.5%). These isolates comprised six different phage types, as well as a number of isolates that were untypeable or atypical (Table 1) . Of the 24 (38%) isolates that were sequence-typed, all belonged to ST34. Isolates with the same R-type, phage types and STs have been described in many European countries. 3 Recently, the molecular mechanisms for this R-type have been elucidated and found to be localized to a chromosomal region called RR1 (bla TEM , strA-strB, sul2) and RR2 [tet(B)]. 8 We screened all ASSuT+ isolates for the presence of these genes, and the results are presented in Table 1 . Interestingly, all but two isolates that were ASSuT+ but did not show chloramphenicol resistance contained these genes and all of the sampled isolates were ST34. Thus, the data presented would suggest that a similar multidrug-resistant strain is emerging in human Salmonella cases in Canada as well. In the European experience, ASSuT ST34 isolates have been linked to food-producing animals, specifically pork. In Germany, similar drug-resistant genotypes, multilocus variable number tandem repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE) fingerprints have been associated with pigs, retail pork and human isolates of ASSuT Salmonella 4, [5] ,12:i:-. 13 In 2008 Salmonella 4, [5] ,12:i:-, Canada in Canada, it was rare to find Salmonella 4, [5] ,12:i:-in pigs on farms, with only one (1.7%) multidrug-resistant isolate reported, and none was found in abattoir surveillance, but four of eight isolates were identified in clinical isolates from pigs.
14 There were 23 isolates identified with a core ACSSuT+ with 11 different R-types observed (Table 1) . Using PCR, considerable variation was observed in the genotypes of the resistance genes analysed. MLST data on the unique R-types for these isolates revealed a second clonal group ST19, which comprised 15 isolates with a minimal R-type of ACSSuT (Table 1) . ST19 varies from ST34 by only a single nucleotide change in the dnaN locus, which suggests that the two antimicrobial types are closely related. However, the majority of isolates that were multidrug resistant including resistance to chloramphenicol fell into this cluster. The antimicrobial resistance genes we identified in the ACSSuT pattern were different from those in the ASSuT ST34 genotype (Table 1) .
Finally, the emergence of extended-spectrum b-lactamase resistance is a growing concern in Salmonella as it limits the use of frontline antimicrobials to treat severe infections. In this study, four isolates were resistant to ceftiofur, a third-generation cephalosporin used in the agri-food industry. Of these, two isolates were identified that contained CTX-M genes (bla CTX-M-55 and bla CTX-M-57 ), both of which had the R-type AmCfCxCGSSuT (Table 1) , but these were identified from different provinces and years. In addition, two isolates harboured a bla CMY-2 gene, one had an R-type of AcACeCfCxCSSuT (PT193), while the other was AcACeCfCxCpCGSSuTTm (PT191). Both of these isolates were identified from different provinces and years ( Table 1) . The bla CTX-M-55 was previously identified in Salmonella 4, [5] ,12:i:-from the USA in 2007, and interestingly it was isolated from a patient with no travel history. 15 bla CTX-M-57 was first described in an isolate of Salmonella Typhimurium from a patient in the UK with a previous travel history to Thailand. 16 To our knowledge, this is the first report of bla CMY-2 identified in Salmonella 4, [5] ,12:i:-. bla CMY-2 is widespread in Canada, being found in Escherichia coli from water, animal and human sources and is particularly common in Salmonella Heidelberg from both chicken and retail poultry meat and human cases.
17,18
Conclusions
The number of Salmonella 4, [5] ,12:i:-infections continues to increase in Canada, with an increasing proportion being found to be multidrug resistant. The isolates can be stratified into two groups; (i) the ASSuT phenotype associated with ST34, which has been described in many European Union countries; and (ii) the ACSSuT phenotype, which has been associated with ST19, has different molecular antimicrobial resistance mechanisms from ST34, and appears to have emerged in Spain. Further studies are required to determine whether these cases are associated with travel or related to food and animal sources in Canada, as linkages to zoonotic transmission, specifically in pigs, have been reported in the European Union for both STs. 19 
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